Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousBone MarrowGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningBone Marrow CellsHematologic NeoplasmsHematopoietic Stem Cell MobilizationHematopoietic Stem CellsGraft SurvivalTransplantation ChimeraGranulocyte Colony-Stimulating FactorStem CellsWhole-Body IrradiationBusulfanCombined Modality TherapyTissue DonorsAntigens, CD34LeukapheresisCyclophosphamideMelphalanTreatment OutcomeLeukemiaRecurrenceBone and BonesMultiple MyelomaHistocompatibility TestingHistocompatibilityRemission InductionAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationBlood Component RemovalMyeloablative AgonistsHematopoiesisTransplantation, IsogeneicLiver TransplantationLymphoma, Non-HodgkinImmunosuppressive AgentsLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetrospective StudiesBone Marrow DiseasesTime FactorsBone Marrow PurgingGraft vs Leukemia EffectEtoposideSurvival AnalysisDisease-Free SurvivalMyelodysplastic SyndromesLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival RateAntineoplastic Agents, AlkylatingInfectionCytarabineImmunosuppressionSalvage TherapyKidney TransplantationGraft vs Tumor EffectCytomegalovirus InfectionsThiotepaVidarabineHematologic DiseasesTransplantation ImmunologyT-LymphocytesHLA AntigensMesenchymal Stem Cell TransplantationBlood CellsCarmustineMice, Inbred C57BLHodgkin DiseaseAcute DiseaseCell DifferentiationCyclosporineFollow-Up StudiesLymphomaLeukocyte TransfusionLymphocyte TransfusionFatal OutcomeHepatic Veno-Occlusive DiseaseVincristineCell TransplantationLeukemia, MyeloidGraft RejectionRadiation ChimeraFlow CytometryBone Marrow ExaminationPOEMS SyndromeColony-Forming Units AssayImmunophenotypingBone RemodelingPlatelet CountBlood Cell CountCells, CulturedAmyloidosis